Identifying a Protein Linked to Prostate Cancer
Author Information
Author(s): Fosså A, Siebert R, Aasheim H-C, Mælandsmo G M, Berner A, Fosså S D, Paus E, Smeland E B, Gaudernack G
Primary Institution: The Norwegian Radium Hospital
Hypothesis
Can the nucleolar protein No55 serve as a tumour-associated autoantigen in prostate cancer patients?
Conclusion
The study found that the nucleolar protein No55 is expressed more in prostate cancer tissues and is associated with the presence of antibodies in patients.
Supporting Evidence
- No55 was expressed at higher levels in prostate cancer tissues compared to normal tissues.
- Antibodies to No55 were found in 7 out of 47 prostate cancer patients.
- No55 gene was located on chromosome 17q21, a region often deleted in prostate cancer.
Takeaway
Researchers found a protein called No55 that is more common in prostate cancer patients, which could help in future cancer studies.
Methodology
Immunoscreening of a cDNA expression library and reverse transcriptase/polymerase chain reaction were used to analyze the expression of No55.
Participant Demographics
The study included 47 prostate cancer patients and 20 healthy male controls.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website